BioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by October

On Tuesday, BioNTech (NASDAQ:BNTX) confirmed what its big pharma partner, Pfizer (NYSE:PFE), had already let out of the bag: The companies hope to have phase 3 results for their coronavirus vaccine candidate by October.